For Release: July 11, 2011
Contact:
David Corriveau 603-653-1978 david.a.corriveau@hitchcock.org
Stone, Goodney earn grants from peers in vascular surgery
Philip P. Goodney, MD
David Stone, MD
Chicago—Dartmouth vascular surgeons Philip P. Goodney, MD, and David Stone, MD, received grants toward their research projects during the Vascular Annual Meeting of the Society for Vascular Surgery (SVS) in Chicago in mid-June.
The Society for Vascular Surgery Foundation and the American College of Surgeons (ACS) conferred the Mentored Clinical Scientist Development Award to Goodney in support of his current research project, "Understanding Variation in Treatment Intensity with Lower Extremity Peripheral Artery Disease (PAD)." The award, aimed at helping surgeon-scientists in the early stages of their research careers, provides $50,000 annually for five years of intensive, supervised research and career-development experience in biomedical or behavioral research, including translational research. Funding for the award also comes from the National Heart, Lung and Blood Institute (NHLBI), the National Institutes of Health (NIH), and the federal Department of Health and Human Services (DHHS) also contribute.
Goodney has served on the vascular-surgery staff at Dartmouth-Hitchcock Medical Center (DHMC) since 2008, and is an affiliated faculty member of The Dartmouth Institute for Health Policy and Clinical Practice (TDI), within the Center for Health Policy Research.
"I am very grateful to receive this award from the Society for Vascular Surgery, as it will help support the development of my research career over the next several years," Goodney says. "I'm most appreciative of the support of my faculty partners in vascular surgery and my research colleagues at TDI - especially my faculty mentor, Dr. Elliott Fisher. I look forward to participating in these future efforts."
The SVS also awarded $15,000 - one of three Clinical Research Seed Grants - to Stone, an assistant professor of surgery at DMS, to further his project, "Depression, a Novel Risk Factor for Peripheral Vascular Disease." The seed grants, covering laboratory assays, imaging studies, data collection, and statistical support, are designed to encourage clinical investigators to start projects with the potential to develop into larger studies attracting support from industrial and government sources.
"This project will hopefully be the beginning of what I believe is a novel pilot study to determine whether clinical depression can be a risk factor for developing peripheral vascular disease," Stone said. "Establishing this link would have the potential to identify an at-risk patient population for vascular disease and a new line of potential therapies."
More information about the SVS is available at www.vascularweb.org.
-DMS-
